De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Agilent Technologies Dividend

Dividend criteriumcontroles 0/6

Agilent Technologies is een dividendbetalend bedrijf met een huidig rendement van 0.64%.

Belangrijke informatie

0.7%

Dividendrendement

19%

Uitbetalingsratio

Gemiddelde opbrengst industrie	0.3%
Volgende betaaldatum dividend	n/a
Ex-dividenddatum	n/a
Dividend per aandeel	US$0.944
Winst per aandeel	US$4.92
Dividendrendementsvoorspelling	0.8%

Recente dividendupdates

Recent updates

With EPS Growth And More, Agilent Technologies (NYSE:A) Makes An Interesting Case

Sep 23

These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Reasonably Well

Apr 05

Agilent Technologies: Cash Flow Returns On Investments And Conventional All Point To A Hold

Mar 12

Agilent Technologies Hit A Homerun

Dec 24

Agilent: A Wide Moat Company Expected To Return To Growth In 2024 (Rating Upgrade)

Dec 08

Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly

Dec 07

Agilent Technologies: Looking Undervalued Heading Into Earnings

Nov 17

Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Oct 26

Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart

Sep 26

Is It Too Late To Consider Buying Agilent Technologies, Inc. (NYSE:A)?

Sep 08

Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly

Aug 21

Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)

Jul 23

Agilent Technologies - A Wealth Compounder 30% Below Its Highs

Jul 13

Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today

Jul 10

What Is Agilent Technologies, Inc.'s (NYSE:A) Share Price Doing?

May 28

Agilent Technologies Stock: Starting To Look Appealing

May 25

These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Safely

Apr 17

Calculating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Apr 03

Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today

Mar 21

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: A betaalt geen noemenswaardig dividend uit voor de US markt. Daarom is het niet nodig om te controleren of de betalingen stabiel zijn.

Groeiend dividend: A betaalt geen noemenswaardig dividend uit voor de US markt. Daarom is het niet nodig om te controleren of de betalingen toenemen.

Dividendrendement versus markt

Agilent Technologies Dividendrendement versus markt

Hoe verhoudt A dividendrendement zich tot de markt?
Segment	Dividendrendement
Bedrijf (A)	0.7%
Markt onderkant 25% (US)	1.4%
Markt Top 25% (US)	4.4%
Gemiddelde industrie (Life Sciences)	0.3%
Analist prognose (A) (tot 3 jaar)	0.8%

Opmerkelijk dividend: Het dividend van A ( 0.64% ) is niet noemenswaardig vergeleken met de onderste 25% van de dividendbetalers op de US markt ( 1.43% ).

Hoog dividend: Het dividend A ( 0.64% ) is laag vergeleken met de top 25% van dividendbetalers in de US markt ( 4.29% ).

Agilent Technologies Dividend

Dividend criteriumcontroles 0/6

Belangrijke informatie

Recente dividendupdates

Agilent Technologies, Inc. Announces Quarterly Dividend, Payable on October 23, 2024

Agilent Technologies, Inc. Announces Quarterly Dividend, Payable on July 24, 2024

Agilent Technologies Inc. Increases Quarterly Cash Dividend, Payable on January 24, 2024

Upcoming dividend of US$0.23 per share at 0.8% yield

Agilent Technologies, Inc. Announces Quarter Dividend, Payable on October 25, 2023

Upcoming dividend of US$0.23 per share at 0.8% yield

Recent updates

Insider notifies of intention to sell stock

With EPS Growth And More, Agilent Technologies (NYSE:A) Makes An Interesting Case

Third quarter dividend of US$0.24 announced

Agilent Technologies, Inc. Announces Quarterly Dividend, Payable on October 23, 2024

Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues

Agilent: A 'Buy' Due To Growing Biopharma, PFAS, And Semi

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Agilent Technologies, Inc. Provides Financial Guidance for the Fourth Quarter of Fiscal 2024 and Revised Financial Guidance for the Full Year of Fiscal 2024

Agilent Technologies, Inc. Announces Innovative J&W 5Q GC/MS Columns for Superior Gas Chromatograph Performance

A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Agilent Technologies, Inc. Receives FDA Approval for Mage-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy

Agilent Technologies, Inc. (NYSE:A) acquired Sigsense Technologies, Inc.

Agilent: Making A Move To Ignite Some Growth

Agilent Technologies, Inc. Introduces New ProteoAnalyzer at Singapore Cell and Gene Therapy Pan Asia Summit

Agilent Technologies, Inc. to Report Q3, 2024 Results on Aug 21, 2024

Agilent Technologies (NYSE:A) Has A Pretty Healthy Balance Sheet

Agilent Technologies, Inc.(NYSE:A) dropped from Russell 1000 Growth-Defensive Index

Now 20% undervalued after recent price drop

Agilent Technologies, Inc Appoints Bret Dimarco as Senior Vice President and Chief Legal Officer and Secretary

Insider recently sold US$2.0m worth of stock

Agilent Technologies, Inc. Is Introducing Two New Products At the 72Nd Asms Conference on Mass Spectrometry and Allied Topics

Price target decreased by 7.2% to US$140

Second quarter 2024 earnings: EPS misses analyst expectations

Agilent Technologies, Inc. Provides Financial Guidance for the Third Quarter of Fiscal 2024 and Revises Financial Guidance for the Full Year of Fiscal 2024

First quarter dividend of US$0.24 announced

Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors

Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors

Is Agilent A Buy Before Earnings? Examining The Pros And Cons

Agilent Technologies, Inc. Announces Quarterly Dividend, Payable on July 24, 2024

Should You Investigate Agilent Technologies, Inc. (NYSE:A) At US$154?

Subdued Growth No Barrier To Agilent Technologies, Inc.'s (NYSE:A) Price

Agilent Technologies, Inc. to Report Q2, 2024 Results on May 29, 2024

Agilent Announces the NovoCyte Opteon, A Cutting-Edge Spectral Flow Cytometry Solution

Agilent Technologies, Inc. Appoints Simon May as President of the Diagnostics and Genomics Group, Effective May 6, 2024

These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Reasonably Well

Agilent Technologies, Inc. At AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics

Agilent Technologies Inc. Launches New Advanced Dilution System to Increase Lab Efficiency

First quarter dividend of US$0.24 announced

Agilent Technologies: Cash Flow Returns On Investments And Conventional All Point To A Hold

Agilent Technologies, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2024

Agilent Technologies, Inc. Announces CEO Changes, effective May 1, 2024

Agilent Technologies, Inc. to Report Q1, 2024 Results on Feb 27, 2024

Agilent Technologies, Inc. Announces New Proteoanalyzer System

Agilent Technologies Hit A Homerun

Agilent Technologies, Inc., Annual General Meeting, Mar 14, 2024

Agilent Makes Strategic Updates to Organizational Structure

Insider recently sold US$2.0m worth of stock

Insider notifies of intention to sell stock

CEO, President & Director notifies of intention to sell stock

Agilent: A Wide Moat Company Expected To Return To Growth In 2024 (Rating Upgrade)

Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly

Agilent Technologies Inc. Announces the Addition of Water Immersion and New Confocal Spinning Disk Technology to the Biotek Cytation C10 Confocal Imaging Reader

Full year 2023 earnings: EPS exceeds analyst expectations

Agilent Technologies, Inc. Provides Earnings Guidance for the First Quarter and Fiscal Year 2024

Agilent Technologies: Looking Undervalued Heading Into Earnings

Agilent Technologies Inc. Increases Quarterly Cash Dividend, Payable on January 24, 2024

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Agilent Technologies, Inc. Announces Resignation of Sam Raha as Senior Vice President of the Company and President of the Diagnostics and Genomics Group

Now 20% undervalued after recent price drop

Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Agilent Technologies, Inc. to Report Q4, 2023 Results on Nov 20, 2023

Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart

Upcoming dividend of US$0.23 per share at 0.8% yield

Agilent Technologies, Inc. Announces Quarter Dividend, Payable on October 25, 2023

Exact Sciences Corporation (NasdaqCM:EXAS) agreed to acquire Resolution Bioscience, Inc. from Agilent Technologies, Inc. (NYSE:A).

Is It Too Late To Consider Buying Agilent Technologies, Inc. (NYSE:A)?

Agilent Technologies, Inc. Announces Management Changes

Agilent Technologies, Inc. Appoints Philip Binns as President of Life Sciences and Applied Markets Group

New minor risk - Earnings quality